BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 35197102)

  • 1. Optogenetics: implications for Alzheimer's disease research and therapy.
    Mirzayi P; Shobeiri P; Kalantari A; Perry G; Rezaei N
    Mol Brain; 2022 Feb; 15(1):20. PubMed ID: 35197102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural changes in Alzheimer's disease from circuit to molecule: Perspective of optogenetics.
    Yang Q; Song D; Qing H
    Neurosci Biobehav Rev; 2017 Aug; 79():110-118. PubMed ID: 28522119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optogenetic stimulation: Understanding memory and treating deficits.
    Barnett SC; Perry BAL; Dalrymple-Alford JC; Parr-Brownlie LC
    Hippocampus; 2018 Jul; 28(7):457-470. PubMed ID: 29742814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optogenetics: Illuminating neuronal circuits of memory formation.
    Ehmann N; Pauls D
    J Neurogenet; 2020 Mar; 34(1):47-54. PubMed ID: 31908173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic stimulation of serotonin nuclei retrieve the lost memory in Alzheimer's disease.
    Bostancıklıoğlu M
    J Cell Physiol; 2020 Feb; 235(2):836-847. PubMed ID: 31332785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.
    Zare D; Rajizadeh MA; Maneshian M; Jonaidi H; Sheibani V; Asadi-Shekaari M; Yousefi M; Esmaeilpour K
    Psychopharmacology (Berl); 2021 Jun; 238(6):1645-1656. PubMed ID: 33624157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optogenetic revolution in memory research.
    Goshen I
    Trends Neurosci; 2014 Sep; 37(9):511-22. PubMed ID: 25022518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illuminating Neural Circuits in Alzheimer's Disease.
    Ying Y; Wang JZ
    Neurosci Bull; 2021 Aug; 37(8):1203-1217. PubMed ID: 34089505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic Plasticity, Dementia and Alzheimer Disease.
    Skaper SD; Facci L; Zusso M; Giusti P
    CNS Neurol Disord Drug Targets; 2017; 16(3):220-233. PubMed ID: 28088900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits.
    Ma T; Trinh MA; Wexler AJ; Bourbon C; Gatti E; Pierre P; Cavener DR; Klann E
    Nat Neurosci; 2013 Sep; 16(9):1299-305. PubMed ID: 23933749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
    Hashimoto M; Masliah E
    Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optogenetic activation of parvalbumin and somatostatin interneurons selectively restores theta-nested gamma oscillations and oscillation-induced spike timing-dependent long-term potentiation impaired by amyloid β oligomers.
    Park K; Lee J; Jang HJ; Richards BA; Kohl MM; Kwag J
    BMC Biol; 2020 Jan; 18(1):7. PubMed ID: 31937327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer's disease.
    Ma T; Klann E
    J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):140-148. PubMed ID: 22122128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optogenetically-inspired neuromodulation: Translating basic discoveries into therapeutic strategies.
    Murphy C; Matikainen-Ankney B; Chang YH; Copits B; Creed MC
    Int Rev Neurobiol; 2021; 159():187-219. PubMed ID: 34446246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optogenetic stimulation of CA3 pyramidal neurons restores synaptic deficits to improve spatial short-term memory in APP/PS1 mice.
    Yang Q; Song D; Xie Z; He G; Zhao J; Wang Z; Dong Z; Zhang H; Yang L; Jiang M; Wu Y; Shi Q; Li J; Yang J; Bai Z; Quan Z; Qing H
    Prog Neurobiol; 2022 Feb; 209():102209. PubMed ID: 34953962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Alterations in the Olfactory Neuronal Circuit Occur before Hippocampal Plasticity Deficits in the P301S Mouse Model of Tauopathy: Implications for Early Diagnosis and Translational Research in Alzheimer's Disease.
    Ahnaou A; Rodriguez-Manrique D; Biermans R; Embrechts S; Manyakov NV; Drinkenburg WH
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Estradiol on Neurogenesis and Cognitive Functions in Alzheimer's Disease.
    Sahab-Negah S; Hajali V; Moradi HR; Gorji A
    Cell Mol Neurobiol; 2020 Apr; 40(3):283-299. PubMed ID: 31502112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optogenetically inspired deep brain stimulation: linking basic with clinical research.
    Lüscher C; Pollak P
    Swiss Med Wkly; 2016; 146():w14278. PubMed ID: 27045196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.
    Jiang L; Huang M; Xu S; Wang Y; An P; Feng C; Chen X; Wei X; Han Y; Wang Q
    Mol Neurobiol; 2016 Aug; 53(6):3832-3841. PubMed ID: 26160762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.